NIH Launches Clinical Trials For Long COVID Treatments

August 1, 2023 Coronavirus, Medicine

Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of Health said Monday, opening enrollment for the first of an array of federally-funded studies aimed at evaluating treatments for long-term symptoms still faced by many COVID-19 survivors.

They will begin with a study into using Pfizer’s Paxlovid antiviral pills, the NIH announced, which are currently only approved by the Food and Drug Administration to treat COVID-19 early during an infection. Another arm of the trials, titled RECOVER-NEURO, will soon test three approaches aimed at helping with issues like brain fog and memory problems.

Around 5% of Americans say they are continuing to face limits to their activity as a result of long COVID, according to survey results from the Centers for Disease Control and Prevention.

Read the full article.

Researchers will test a range of potential treatments, from melatonin to Paxlovid, to see if they relieve symptoms of long COVID.
https://t.co/rskrMjqlu9

— CBS News (@CBSNews) August 1, 2023